Straumann Holding AG Shares Outstanding 2012-2021 | SAUHY

Straumann Holding AG shares outstanding history from 2012 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Straumann Holding AG shares outstanding for the quarter ending December 31, 2021 were M, a NAN% increase year-over-year.
  • Straumann Holding AG 2021 shares outstanding were 1.596B, a 0.21% increase from 2020.
  • Straumann Holding AG 2020 shares outstanding were 1.593B, a 0.07% increase from 2019.
  • Straumann Holding AG 2019 shares outstanding were 1.591B, a 0.21% increase from 2018.
Straumann Holding AG Annual Shares Outstanding
(Millions of Shares)
2021 1,596
2020 1,593
2019 1,591
2018 1,588
2017 1,557
2016 1,573
2015 1,583
2014 1,574
2013 1,545
2012 1,544
2011
Straumann Holding AG Quarterly Shares Outstanding
(Millions of Shares)
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.515B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47